TCL Archive Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years September 28, 2012
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results April 4, 1986